126 related articles for article (PubMed ID: 4447784)
21. Cancer diagnostic test of Field and Caspary: Part II. A review and interpretation of the collected data.
Kast RE
Med Hypotheses; 1980 Jan; 6(1):63-72. PubMed ID: 6155596
[TBL] [Abstract][Full Text] [Related]
22. [Use of the macrophage-electrophoretic-mobility test in the diagnosis of tumours of the central nervous system (author's transl)].
Meyer-Rienecker H; Jenssen HL; Köhler H; Günther JK
Dtsch Med Wochenschr; 1975 Mar; 100(11):538-43. PubMed ID: 163724
[TBL] [Abstract][Full Text] [Related]
23. [Macrophage electrophoretic mobility inhibition test (MET) in immunological diagnosis of malignant lymphomas in Papio baboons].
Indzhiia LV; Iakovleva LA; Lapin BA; Tsaturian TN; Malkovskiĭ M
Vopr Onkol; 1980; 26(11):66-71. PubMed ID: 7456428
[TBL] [Abstract][Full Text] [Related]
24. [Pre- and postoperative reactivity of breast cancer patients to tumor associated antigens and HEP in the macrophage electrophoresis mobility (MEM) test].
Ladusch M; Schäffner H; Ullmann L; Littmann M; Reimann S; Gindl P; Ambrosius H
Arch Geschwulstforsch; 1982; 52(6):469-78. PubMed ID: 6186223
[TBL] [Abstract][Full Text] [Related]
25. The linoleic acid depression (LAD) test for multiple sclerosis using the macrophage electrophoretic mobility (MEM) test.
Jenssen HL; Meyer-Rienecker HJ; Köhler H; Günther JK
Acta Neurol Scand; 1976 Jan; 53(1):51-60. PubMed ID: 1251680
[TBL] [Abstract][Full Text] [Related]
26. Cross-reactions among mouse tumors of different etiology as detected by macrophage electrophoretic mobility (MEM) test.
Pasternak L; Jenssen HL; Köhler H; Pasternak G
Eur J Cancer (1965); 1976 May; 12(5):389-93. PubMed ID: 954796
[No Abstract] [Full Text] [Related]
27. Macrophage migration inhibition factor test in breast tumors.
Gutman H; Kott I; Rabinerson D; Reiss R
Isr J Med Sci; 1986 Nov; 22(11):812-6. PubMed ID: 3793437
[TBL] [Abstract][Full Text] [Related]
28. Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation.
Pritchard JA; Moore JL; Sutherland WH; Joslin CA
Lancet; 1972 Sep; 2(7778):627-9. PubMed ID: 4116778
[No Abstract] [Full Text] [Related]
29. A clinical assessment of fluorescence polarisation changes in lymphocytes stimulated by phytohaemagglutinin (PHA) in malignant and benign diseases.
Pritchard JA; Sutherland WH; Siddall JE; Bater AJ; Kerby IJ; Deeley TJ; Griffith G; Sinclair R; Davies BH; Rimmer A; Webster DJ
Eur J Cancer Clin Oncol; 1982 Jul; 18(7):651-9. PubMed ID: 6751831
[TBL] [Abstract][Full Text] [Related]
30. The macrophage electrophoretic mobility assay in patients with renal cell carcinoma.
Malkovský M; Bubeník J; Jakoubková J; Suhajová E; Indrová M; Jandlová T; Símová J
Neoplasma; 1981; 28(2):245-51. PubMed ID: 7254439
[TBL] [Abstract][Full Text] [Related]
31. The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics.
Carnegie PR; Caspary EA; Dickinson JP; Field EJ
Clin Exp Immunol; 1973 May; 14(1):37-45. PubMed ID: 4716103
[TBL] [Abstract][Full Text] [Related]
32. Macrophage electrophoretic migration (MEM) test for lymphocyte sensitization: some practical experiences in macrophage selection.
Shenton BK; Hughes D; Field EJ
Br J Cancer Suppl; 1973 Aug; 1():215-8. PubMed ID: 4804280
[TBL] [Abstract][Full Text] [Related]
33. [The electrophoretic-mobility-(EM) test: a method for discrimination of malignant and non-malignant tumors (author's transl)].
Tautz C; Schneider W; Laier E; Brügmann G
Klin Wochenschr; 1978 Feb; 56(4):175-85. PubMed ID: 75286
[No Abstract] [Full Text] [Related]
34. [Determination of the MSF (macrophage slowing factor) release by phytohemagglutinin using the macrophage electrophoretic mobility test (MEM test). I. Dependency of release on incubation time, phytohemagglutinin and cell concentration].
Metzner G; Jäger L
Acta Biol Med Ger; 1980; 39(2-3):223-7. PubMed ID: 6999821
[TBL] [Abstract][Full Text] [Related]
35. [The macrophage electrophoretic mobility LAD test--a diagnostic method for multiple sclerosis (author's transl)].
Meyer-Rienecker H; Jenessen HL; Köhler H; Günther JK
J Neurol; 1976 Feb; 211(3):229-40. PubMed ID: 55489
[TBL] [Abstract][Full Text] [Related]
36. Biological and clinical significance of macrophage electrophoretic mobility (MEM) test in tumor immunity.
Nakajima T; Isojima K; Iwaguchi T
Cell Mol Biol Incl Cyto Enzymol; 1979; 25(5):355-61. PubMed ID: 394842
[No Abstract] [Full Text] [Related]
37. Application of the macrophage migration inhibition test to screen patients with early cancer and obtain prognostic determinations of cancer treatment.
Akiyama T; Yamura N
Jpn J Microbiol; 1976 Apr; 20(2):131-40. PubMed ID: 948144
[TBL] [Abstract][Full Text] [Related]
38. [Clinical application of macrophage migration inhibition test].
Akiyama T; Yamaura N
Rinsho Byori; 1973 Jan; 21(1):52-8. PubMed ID: 4575082
[No Abstract] [Full Text] [Related]
39. [The electrophoretic-mobility-test (EMT) in the diagnosis of malignancies (author's transl)].
Douwes FR; Hanke R; Mross K
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976 Dec; 87(3):281-90. PubMed ID: 138274
[No Abstract] [Full Text] [Related]
40. [The macrophage electrophoresis mobility (MEM) test for detection of cell sensitivity: technical analyses. I. Guinea pig peritoneal cells as indicator cells in the MEM test].
Gryschek G; Schlott B; Strecker K
Acta Biol Med Ger; 1982; 41(9):837-46. PubMed ID: 7164703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
